Title |
Efficacy and safety of pharmacological treatments for neuroborreliosis—protocol for a systematic review
|
---|---|
Published in |
Systematic Reviews, October 2014
|
DOI | 10.1186/2046-4053-3-117 |
Pubmed ID | |
Authors |
Rick Dersch, Michael H Freitag, Stefanie Schmidt, Harriet Sommer, Gerta Rücker, Sebastian Rauer, Joerg J Meerpohl |
Abstract |
Neuroborreliosis is a tick-borne infectious disease of the nervous system caused by Borrelia burgdorferi. Common clinical manifestations of neuroborreliosis are cranial nerve dysfunctions, polyradiculoneuritis, and meningitis. Diagnosis is usually based on clinical presentation, serologic testing, and analysis of cerebrospinal fluid. Many aspects of pharmacological treatment, such as choice of drug, dosage, and duration are subject of intense debate, leading to uncertainties in patients and healthcare providers alike. To approach the questions regarding pharmacological treatment of neuroborreliosis, we will perform a systematic review. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 33% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 3% |
Unknown | 65 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 18% |
Student > Master | 9 | 13% |
Student > Ph. D. Student | 8 | 12% |
Student > Doctoral Student | 8 | 12% |
Student > Bachelor | 8 | 12% |
Other | 12 | 18% |
Unknown | 10 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 33% |
Nursing and Health Professions | 7 | 10% |
Psychology | 7 | 10% |
Biochemistry, Genetics and Molecular Biology | 3 | 4% |
Computer Science | 3 | 4% |
Other | 11 | 16% |
Unknown | 14 | 21% |